The University of Chicago Header Logo

Connection

Douglas Merkel to Antimetabolites, Antineoplastic

Back to Details
This is a "connection" page, showing publications Douglas Merkel has written about Antimetabolites, Antineoplastic.
Douglas Merkel
Connection Strength
0.159
Antimetabolites, Antineoplastic
  1. Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
    View in: PubMed
    Score: 0.159
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.